CIK 0001420565 · Non-accelerated filer<br>Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 134196017
- Phone
- 7378021989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-30 | Annis Allen SVP, Research | Grant or award · Stock Option (right to buy) | +313,000 | 313,000 | ||
| 2022-03-22 | Wanstall Rick See Remarks | Grant or award · Stock Option (right to buy) | +393,000 | 393,000 | ||
| 2022-03-22 | Annis Allen SVP, Research | Grant or award · Stock Option (right to buy) | +313,000 | 313,000 | ||
| 2022-03-22 | Aivado Manuel See Remarks | Grant or award · Stock Option (right to buy) | +1,133,000 | 1,133,000 | ||
| 2022-03-22 | Vukovic Vojo Chief Medical Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2021-06-15 | Bailey Jeffrey Allen Director | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2021-06-15 | Aivado Manuel See Remarks | Grant or award · Stock Option (right to buy) | +2,440,000 | 2,440,000 | ||
| 2021-06-15 | Morrison Jodie Pope Director | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2021-06-15 | Ambros Reinhard J. Director | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2021-06-15 | Wanstall Rick See Remarks | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2021-06-15 | MCKEE WILLIAM Director | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2021-06-15 | VON RICKENBACH JOSEF H Director | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2021-06-15 | Vukovic Vojo Chief Medical Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2021-06-15 | Sigal Nolan Howard Director | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2021-06-15 | Annis Allen SVP, Research | Grant or award · Stock Option (right to buy) | +474,000 | 474,000 | ||
| 2021-01-08 | Satter Muneer A See Remarks | Purchase | +9,000,000 | $1.10 | $9.9M | 16,609,449 |
| 2020-06-23 | Wanstall Rick See Remarks | Grant or award · Stock Option (right to buy) | +91,000 | 91,000 | ||
| 2020-06-17 | Sigal Nolan Howard Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2020-06-17 | VON RICKENBACH JOSEF H Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2020-06-17 | MCKEE WILLIAM Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 |
Page 6 of 10 · 192 trades